Article Details
Retrieved on: 2024-12-09 17:10:35
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Hudson Therapeutics, a US subsidiary of Shaperon, participating in key biotech conferences and focusing on developing therapies, including for COVID-19 pneumonia, linking to the pharmaceutical industry in China and global partnerships.
Article found on: www.einpresswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here